DUBLIN–(BUSINESS WIRE)–The “Global Automated and Closed Cell Therapy Market 2024-2029” report has been added to ResearchAndMarkets.com’s offering.
In 2023, the global market for automated and closed cell therapy was valued at $1.5 billion. The market is forecast to grow at a CAGR of 23.9% to reach $5.3 billion at the end of 2029.
The report highlights the current and future market potential of automated and closed cell therapy systems and a detailed analysis of the market drivers, restraints, and opportunities. The report also covers market projections for 2029, a competitive environment, patent, and product analysis. The report provides market estimates and forecasts for automated and closed cell therapy based on automation, cell type, application, and region. The market is segmented into CAR-T cells, stem cells, and other cell types based on cell type.
The increasing demand for regenerative medicine and the growing need for decentralized manufacturing of CAR-T therapies drive the market’s growth. The high cost, integration challenges and regulatory uncertainties challenge the market’s growth.
This report sections the global market by automation type, cell type, application, and region. By automation type, the market is categorized into semi-automated and fully automated. The semi-automated and closed cell therapy segment, which held the largest share in 2023, is expected to grow at a CAGR of 22.2% during the forecast period. The semi-automated and closed cell therapy segment is further categorized into apheresis, expansion, fill-finish, separation, and others based on workflow.
Report Highlights
In terms of application, the clinical segment is forecast to grow at a CAGR of 22.3% during the forecast period. This segment accounted for 82.8% of the market in 2023, reaching a value of $4.1 billion through 2029.
The CAR-T cell therapy segment accounted for 39.5% of the market by cell type in 2023. This segment is expected to grow at a CAGR of 23.8% during the forecast period, reaching a value of $2.1 billion at the end of 2029.
North America held the largest market share of 41.8% by region in 2023. Increasing R&D activities and the growing number of regional service providers are responsible for the high share.
For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast through 2029.
Report Includes
An overview of the current and future global markets for automated and closed cell therapy
Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024 and projected CAGRs through 2029
Estimates of the market size and revenue forecasts, with market share analysis based on the automation type, cell type, application, and region
Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
Overview of the sustainability and ESG trends, with emphasis on the ESG practices followed by leading companies, their ESG rankings and consumer attitudes
Competitive intelligence, including companies’ market shares, recent M&A activity, and venture funding.
Profiles of the leading companies, including Danaher Corp., Thermo Fischer Scientific Inc., Lonza, and Sartorius AG
Company Profiles
Adva Biotechnology
Biospherix Ltd.
Cellares
Danaher Corp.
Fresenius Se & Co. Kgaa
Lonza
Miltenyi Biotec
Sartorius Ag
Terumo Corp.
Thermo Fisher Scientific Inc.
Key Attributes:
Report Attribute
Details
No. of Pages
112
Forecast Period
2024 – 2029
Estimated Market Value (USD) in 2024
$1.8 Billion
Forecasted Market Value (USD) by 2029
$5.3 Billion
Compound Annual Growth Rate
23.9%
Regions Covered
Global
Key Topics Covered:
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Insights
Chapter 2 Market Overview
Overview
Types of Cell Therapy
Applications of Cell Therapy
Regenerative Medicine
Cancer
Autoimmune Disorders
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Point-of-Care Manufacturing in CAR-T Therapies
Growing Demand for Regenerative Medicine
Market Restraints
High Costs and Integration Challenges
Regulatory Uncertainties
Market Opportunities
Increasing Startups in Cell Therapy Manufacturing
Scalable Platforms
Chapter 4 Emerging Technologies and Developments
Introduction
Real-Time Monitoring (RTM) of Operations
Off-the-Shelf Cell Therapies
Miniaturization of Cell Therapy Systems
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Global Automated and Closed Cell Therapy Market by Automation Type
Semi-Automated Cell Therapy
Fully Automated Cell Therapy
Global Automated and Closed Cell Therapy Market by Cell Type
CAR-T Cells
Stem Cells
Other Cell Types
Global Automated and Closed Cell Therapy Market by Application
Market Size and Forecast
Clinical
Commercial
Geographic Breakdown
Global Market for Automated and Closed Cell Therapy by Region
Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 6 Competitive Intelligence
Competitive Landscape
Partnerships
Investments and Funding
Patent Analysis
Chapter 7 Sustainability in the Automated and Closed Cell Therapy Market
Introduction
Sustainability in the Automated and Closed Cell Therapy Industry
Understanding the ESG Data
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks
Chapter 8 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/3jnkke
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900